Authors:
HANNIGAN MP
CASS GR
PENMAN BW
CRESPI CL
LAFLEUR AL
BUSBY WF
THILLY WG
SIMONEIT BRT
Citation: Mp. Hannigan et al., BIOASSAY-DIRECTED CHEMICAL-ANALYSIS OF LOS-ANGELES AIRBORNE PARTICULATE MATTER USING A HUMAN CELL MUTAGENICITY ASSAY, Environmental science & technology, 32(22), 1998, pp. 3502-3514
Authors:
BUSBY WF
SMITH H
CRESPI CL
PENMAN BW
LAFLEUR AL
Citation: Wf. Busby et al., MUTAGENICITY OF THE ATMOSPHERIC TRANSFORMATION PRODUCTS 2-NITROFLUORANTHENE AND 2-NITRODIBENZOPYRANONE IN SALMONELLA AND HUMAN CELL FORWARDMUTATION ASSAYS, Mutation research. Genetic toxicology and environmental mutagenesis, 389(2-3), 1997, pp. 261-270
Authors:
CRESPI CL
PENMAN BW
STEIMEL TD
SMITH T
YANG CS
SUTTER TR
Citation: Cl. Crespi et al., DEVELOPMENT OF A HUMAN LYMPHOBLASTOID CELL-LINE CONSTITUTIVELY EXPRESSING HUMAN CYP1B1 CDNA - SUBSTRATE-SPECIFICITY WITH MODEL SUBSTRATES AND PROMUTAGENS, Mutagenesis, 12(2), 1997, pp. 83-89
Authors:
CODE EL
CRESPI CL
PENMAN BW
GONZALEZ FJ
CHANG TKH
WAXMAN DJ
Citation: El. Code et al., HUMAN CYTOCHROME P4502B6 - INTERINDIVIDUAL HEPATIC EXPRESSION, SUBSTRATE-SPECIFICITY, AND ROLE IN PROCARCINOGEN ACTIVATION, Drug metabolism and disposition, 25(8), 1997, pp. 985-993
Citation: Lp. Chen et al., COEXPRESSION OF CYTOCHROME P4502A6 AND HUMAN NADPH-P450 OXIDOREDUCTASE IN THE BACULOVIRUS SYSTEM, Drug metabolism and disposition, 25(4), 1997, pp. 399-405
Citation: Cl. Crespi et al., DEVELOPMENT OF CACO-2 CELLS EXPRESSING HIGH-LEVELS OF CDNA-DERIVED CYTOCHROME P4503A4, Pharmaceutical research, 13(11), 1996, pp. 1635-1641
Authors:
DURANT JL
BUSBY WF
LAFLEUR AL
PENMAN BW
CRESPI CL
Citation: Jl. Durant et al., HUMAN CELL MUTAGENICITY OF OXYGENATED, NITRATED AND UNSUBSTITUTED POLYCYCLIC AROMATIC-HYDROCARBONS ASSOCIATED WITH URBAN AEROSOLS, Mutation research. Genetic toxicology testing, 371(3-4), 1996, pp. 123-157
Authors:
CRESPI CL
STEIMEL DT
PENMAN BW
KORZEKWA KR
FERNANDEZSALGUERO P
BUTERS JTM
GELBOIN HV
GONZALEZ FJ
IDLE JR
DALY AK
Citation: Cl. Crespi et al., COMPARISON OF SUBSTRATE METABOLISM BY WILD-TYPE CYP2D6 PROTEIN AND A VARIANT CONTAINING METHIONINE, NOT VALINE, AT POSITION-374, Pharmacogenetics, 5(4), 1995, pp. 234-243
Citation: Wf. Busby et al., MUTAGENICITY OF BENZO[A]PYRENE AND DIBENZOPYRENES IN THE SALMONELLA-TYPHIMURIUM TM677 AND THE MCL-5 HUMAN CELL FORWARD MUTATION ASSAYS, Mutation research. Genetic toxicology testing, 342(1-2), 1995, pp. 9-16
Citation: Wf. Busby et al., HUMAN CELL MUTAGENICITY OF MONONITROPYRENES AND DINITROPYRENES IN METABOLICALLY COMPETENT MCL-5 CELLS, Mutation research. Genetic toxicology testing, 322(4), 1994, pp. 233-242
Citation: Bw. Penman et al., DEVELOPMENT OF A HUMAN LYMPHOBLASTOID CELL-LINE CONSTITUTIVELY EXPRESSING HUMAN CYP1A1 CDNA - SUBSTRATE-SPECIFICITY WITH MODEL SUBSTRATES AND PROMUTAGENS, Carcinogenesis, 15(9), 1994, pp. 1931-1937
Authors:
CRESPI CL
PENMAN BW
GONZALEZ FJ
GELBOIN HV
GALVIN M
LANGENBACH R
Citation: Cl. Crespi et al., GENETIC TOXICOLOGY USING HUMAN CELL-LINES EXPRESSING HUMAN P-450, Biochemical Society transactions, 21(4), 1993, pp. 1023-1028
Citation: Cl. Crespi et al., HUMAN CELL-LINES, DERIVED FROM AHH-1 TK+ - HUMAN LYMPHOBLASTS, GENETICALLY-ENGINEERED FOR EXPRESSION OF CYTOCHROMES-P450/, Toxicology, 82(1-3), 1993, pp. 89-104
Authors:
NGUYEN T
BRUNSON D
CRESPI CL
PENMAN BW
WISHNOK JS
TANNENBAUM SR
Citation: T. Nguyen et al., DNA DAMAGE AND MUTATION IN HUMAN-CELLS EXPOSED TO NITRIC-OXIDE INVITRO, Proceedings of the National Academy of Sciences of the United Statesof America, 89(7), 1992, pp. 3030-3034